News Feed
May 25, 2017
Northeast Node co-hosting NIDA Director, NH state rep at opioid crisis conference
Together with the Dartmouth Center for Technology and Behavioral Health at the Geisel School of Medicine at Dartmouth, the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network will co-host Dr. Nora Volkow, Director of the National Institute on Drug Abuse, and New Hampshire State Representative Ann McLane Kuster, at a conference focused on New Hampshire’s opioid crisis.
May 22, 2017
April DMI report: NH projecting a 9% increase in OD deaths over 2016
The New Hampshire Drug Monitoring Initiative (DMI) has released its April 2017 Drug Environment Report. As of April, New Hampshire is projected to see a 9% increase in overdose deaths over 2016.
May 19, 2017
Buprenorphine waiver course for PAs, NPs now available
The Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) has big news to announce! A new free course is now available for nurse practitioners and physicians’ assistants to become waivered to prescribe buprenorphine.
The new course covers the required 24-hour training requirement, including an 8-hour waiver training and 16-hour Opioid Use Disorder treatment training.
You can access the course here.
April 1, 2017
Dr. Alan Budney attends the College on Problems of Drug Dependence Advocacy Day on Capitol Hill
On March 28, 2017, Northeast Node Core Investigator Dr. Alan Budney attended the College on Problems of Drug Dependence (CPDD) Advocacy Day on Capitol Hill and met with 28 Congressional offices to advocate for funding for drug abuse research.
Read a summary of the Advocacy Day’s highlights here.
Dr. Budney is the president-elect of CPDD and has been a strong member of the Northeast Node’s Core Investigative team since our inception. Read his biography here.
February 7, 2017
Dr. Lisa Marsch testifies at House Bipartisan Heroin Task Force on NH fentanyl overdose crisis
On Monday, February 6, Dr. Lisa Marsch, Director of the Northeast Node and the Center for Technology and Behavioral Health (CTBH), testified at a Congressional briefing of the House Bipartisan Heroin Task Force.
January 8, 2017
Node study featured in Union Leader
The Northeast Node’s Phase 2 Fentanyl Hot Spot study, Understanding Opioid Overdoses in New Hampshire, was recently featured in the Union Leader. The article explains New Hampshire’s fentanyl-related overdose crisis and how the study aims to answer the question: Why does New Hampshire have such a big problem? You can read the full article here.
January 5, 2017
The Voice of New Hampshire’s Young Adults report outlines perspectives on substance misuse
The New Hampshire Bureau of Drug and Alcohol Services (BDAS) Prevention and Education Services recently completed an extensive study that interviewed 366 young adults in New Hampshire and asked them about their attitudes and perceptions of substance misuse in New Hampshire.
December 13, 2016
Northeast Node co-sponsors Koop symposium on behavioral health stigma
The Northeast Node of the National Drug Abuse Treatment Clinical Trials Network co-sponsored the Dartmouth College 10th annual C. Everett Koop Symposium on Addiction Medicine, Thursday, December 8, 2016. This year’s symposium, “Reducing Behavioral Health Stigma in Healthcare Systems and Communities,” featured speakers from various settings that encounter behavioral health stigma in their daily activities.
November 16, 2016
Drug Reports for Maine, New Hampshire, and Vermont
Each of our partnering states releases reports that compile data on their individual opioid and overdose crises. For information on each state’s individual reports, see below.
Maine
Maine’s report is released annually by the Maine Department of Health and Human Services. The 2015 Substance Abuse Trends in Maine – State Epidemiological Profile can be found here, and with previous reports on the DHHS website.
New Hampshire
New Hampshire’s report is released monthly by the New Hampshire Bureau of Drug and Alcohol Services (BDAS) Drug Monitoring Initiative. Monthly reports can be found on the BDAS website.
Vermont
Vermont’s report is released in multiple formats and can be found on the Vermont Department of Health website. A presentation report is assembled in October, which can be found here.
October 24, 2016
NH releases Drug Monitoring Initiative report for September 2016
The New Hampshire Drug Monitoring Initiative (DMI) has released its September 2016 Drug Environment Report. This report is cumulative of both past year data as well as annual measures that go back as far as 2010.
The Department of Health and Human Services (DHHS)-sponsored DMI is “a holistic strategy to provide awareness and combat drug distribution and misuse.” The DMI collects and reports on drug data from sources in New Hampshire such as public health, law enforcement, emergency medical services, Safe Station, and state emergency departments to name a few.
The September DMI report is available to view below, and is also available on the DHHS website. Previous monthly DMI reports can also be found on the DHHS website.
nh-dmi-drug-environment-report-september-2016-unclassified-2016-2740